Equities

Themis Medicare Ltd

THEMISMED:NSI

Themis Medicare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)205.50
  • Today's Change-1.35 / -0.65%
  • Shares traded12.17k
  • 1 Year change+35.19%
  • Beta1.4037
Data delayed at least 15 minutes, as of May 29 2024 10:49 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • THEMISMED:NSI price rises above 50-day moving average to 218.35 at 10:15 BST
  • THEMISMED:NSI price moved over +2.51% to 218.35
  • THEMISMED:NSI trading volume exceeds daily average by +18.23%
  • THEMISMED:NSI price rises above 50-day moving average to 218.35 at 12:32 BST
  • THEMISMED:NSI price falls below 15-day moving average to 208.55 at 12:51 BST

Key statistics

On Wednesday, Themis Medicare Ltd (THEMISMED:NSI) closed at 205.50, -22.11% below its 52-week high of 263.85, set on Mar 02, 2024.
52-week range
Today
132.61Jul 04 2023263.85Mar 02 2024
Open207.50
High209.05
Low205.20
Bid206.50
Offer205.50
Previous close206.85
Average volume42.11k
Shares outstanding92.04m
Free float19.43m
P/E (TTM)43.81
Market cap19.04bn INR
EPS (TTM)4.72
INR
Annual div (ADY)0.50
INR
Annual div yield (ADY)0.24%
Div ex-dateSep 01 2023
Div pay-dateSep 09 2023
Next div ex-dateJul 12 2024
Next div pay-dateJul 22 2024
Data delayed at least 15 minutes, as of May 29 2024 10:49 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.